Resources

Combining angiotensin II receptor blockade with angiotensin-converting enzyme (ACE) inhibition improved albuminuria and lipid profile compared with either therapy alone in patients with diabetic nephropathy.

Patients with advanced heart failure appear have a significantly increased risk of developing diabetes, starting at 6 years after diagnosis of heart failure, according to the results of a study. ” Recent reports suggest that decreased functional capacity in patients with heart failure may be associated with abnormalities in glucose …

A single-tablet combination of metformin and glibenclamide is more effective at lowering blood glucose than is monotherapy with either drug.

Aventis announced that its basal insulin, Lantus®, has been approved by the U.S. Food and Drug Administration for flexible administration at any time of day.

PIO continues to demonstrate its safety.

Lipid abnormalities remain common in children and adolescents with type 1 diabetes even though they adhere to current dietary recommendations.

New Data Shown to Increase Good Cholesterol Levels Up to 25 Percent and a one percent increase in HDL cholesterol is associated with a one percent lower risk of cardiovascular disease.

The annual direct cost of diabetes in the United States more than doubled between 1997 and 2002, Tommy G. Thompson also announced there are over 17 million people with diabetes and another 16 million with PreDiabetes at a press briefing.

Risk increases with a BMI of 25 or greater

Pioglitazone exerts a greater benefit on insulin sensitivity in recently diagnosed patients with type 2 diabetes. Pioglitazone and metformin improve glycemic control to a similar extent, but pioglitazone exerts a greater benefit on insulin sensitivity in recently diagnosed patients with type 2 diabetes who have not previously received oral antihyperglycaemics